Background: Protoacoustics has emerged as a promising real-time range measurement method for proton therapy. Optical hydrophones (OHs) are considered suitable to detect protoacoustic waves owing to their ultracompact size and high sensitivity. In our previous research, we demonstrated that the time-of-arrival (TOA) measured by an OH showed good agreement with the simulated ground truth in a homogeneous medium.
View Article and Find Full Text PDFPurpose: As part of the 100,000 Genomes Project, we set out to assess the potential viability and clinical impact of reporting genetic variants associated with drug-induced toxicity for patients with cancer recruited for whole-genome sequencing (WGS) as part of a genomic medicine service.
Methods: Germline WGS from 76,805 participants was analyzed for pharmacogenetic (PGx) variants in four genes (, , , ) associated with toxicity induced by five drugs used in cancer treatment (capecitabine, fluorouracil, mercaptopurine, thioguanine, irinotecan). Linking genomic data with prescribing and hospital incidence records, a phenome-wide association study (PheWAS) was performed to identify whether phenotypes indicative of adverse drug reactions (ADRs) were enriched in drug-exposed individuals with the relevant PGx variants.